Company: PHR
Filing Date: 2025-05-28
Form Type: 10-Q
Source: 0001412408-25-000039
Chunk: 101

Company: Phreesia, Inc.
Filing Date: 2025-05-28
Form: 10-Q
Item: Part I, Item 1
Chunk 101
---
Losses reclassified from accumulated other comprehensive income into income (effective portion)Expenses20 — Tax effect reclassified from accumulated other comprehensive income into income (effective portion)Provision for income taxes— —  As of April 30, 2025, the foreign currency forward contract had a maturity of less than 6 months. As of April 30, 2025, the Company estimates that the entire $407 of the net gain recorded in accumulated other comprehensive income (loss) related to its foreign currency cash flow hedge will be reclassified into income within the next 12 months.See Note 3 - Summary of significant accounting policies and Note 9 - Fair value measurements for additional disclosures for derivatives and hedging.

31

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion and analysis of our financial condition and results of operations together with our unaudited consolidated financial statements and related notes and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q and our financial statements and related notes thereto included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2025, filed with the SEC on March 13, 2025. Some of the information contained in this discussion and analysis or set forth elsewhere in this Quarterly Report on Form 10-Q, including information with respect to our plans and strategy for our business, includes forward-looking statements based upon current plans, expectations and beliefs that involve risks and uncertainties. As a result of many factors, including those factors set forth under “Risk Factors” and “Special Note Regarding Forward-Looking Statements: in this Quarterly Report on Form 10-Q, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the follow discussion and analysis.

Financial Highlights

•Total revenue increased 15% to $115.9 million in the three months ended April 30, 2025, as compared to $101.2 million in the three months ended April 30, 2024.

•Net loss was $3.9 million in the three months ended April 30, 2025, as compared to $19.7 million in the three months ended April 30, 2024.

•Adjusted EBITDA was $20.8 million in the three months ended April 30, 2025, as compared to $4.1 million in the